More blood pressure meds recalled for presence of cancer-causing chemical

This Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. (AP Photo/Jacquelyn Martin, File)
Published:
Updated:

WASHINGTON (WTHR) — The FDA has expanded its recall for drugs containing a cancer-causing chemical.

This expansion adds five medications used to treat high blood pressure.

The initial recall came in January. Since then, dozens of medications have been added to the list of prescription drugs that have trace amounts of N-Methylnitrosobutyric acid (NMBA).

The latest recall includes three lots of Losartan Potassium Tablets USP and two lots of Losartan Potassium/Hydrochlorothiazide Tables, USP.

These are the new medications added to the recall:

  • Losartan Potassium Tablets, USP 50mg, 1000 count with expiration date 12/31/2020
  • Losartan Potassium Tablets, USP 100mg, 90 count with expiration date 12/31/2020
  • Losartan Potassium Tablets, USP 100mg, 1000 count with expiration date 2/28/2020
  • Losartan Potassium / Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 count with expiration date 11/30/2020
  • Losartan Potassium / Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 count with expiration date 7/31/2020

The FDA says anyone using the drugs should continue taking the medication because the benefits outweigh the risks.

Filed under: